Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,121 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

NCT01476410

Conditions
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +13 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • NorthwesternU Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study

NCT06714370

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +17 more
Locations
  • Chang Gung Memorial Hospital Kaohsiung City, Taiwan
  • China Medical University Hospital Taichung, Taiwan
  • National Cheng Kung Univeristy Hospital Tainan, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
View Trial Details
Completed

Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma

NCT05032820

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 15 locations
View Trial Details
Completed

Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL

NCT02362997

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +14 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions